ReviewThe Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology2025

Efficacy and safety of tafolecimab a new PCSK9 inhibitor in patients with hyperlipidemia: a systematic review and meta-analysis of randomized controlled trials.

Ali Ashraf Salah Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.